BMGL

Basel Medical Group Ltd
CAPPED RATING

Basel Medical Group Ltd provides healthcare services. The company offers services in the areas of medical specialists, medical supplies and equipment, medical technology, and pharmaceuticals. The company was incorporated in 2023 and is based in Singapore.

Basel Medical Group Ltd (BMGL) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B+); its weakest is Momentum (F).

Quantitative Factor Evaluation • Updated

Overall Rating
2.6 / 5.0
C+
Value
B-
Factor Score 3.0 / 5.0
Growth
B+
Factor Score 3.8 / 5.0
Profitability
B-
Factor Score 3.0 / 5.0
Momentum
F
Factor Score 0.6 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA -20.6
Rev Growth YoY 63.0%
Gross Margin 38.8%
Price Return 3M -94.2%
Price Return 12M -98.0%
Catalyst Signal 0.00
Market Cap $4.1M
TTM Revenue $21.5M
Price / Sales 0.2
ROE -28.7%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 B- (3.0) B+ (3.8) B- (3.0) F (0.6) C+ (2.6) C+ (2.6)
2026-11-10 B- (3.0) A- (3.9) B- (3.0) C- (2.0) C+ (2.6) B- (2.9)
2026-11-03 B- (3.0) A- (4.0) B- (3.1) D+ (1.8) C+ (2.7) B- (2.9)
2026-10-27 B- (3.0) A- (4.1) C (2.2) D (1.3) C+ (2.6) C+ (2.6)
2026-10-20 B- (3.0) A- (4.1) C (2.2) D (1.4) C+ (2.6) C+ (2.7)
Page 1 of 4